AzTrials
AzTrials

Stroke, CardiovascularNCT05414539

OptiCogs: A Multicomponent Intervention to Rehabilitate Cognitive Impairment in People Post-stroke

A study testing OptiCogs Online in people with Stroke, Cardiovascular and Cognitive Impairment, run by University of Limerick at 1 site in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

OptiCogs Online is a complex multicomponent intervention comprising of cognitive, physical activity and educational components. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Cardiovascular, Cognitive Impairment
What is being tested?
OptiCogs Online
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteIreland
Study dates
9 May 2022to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • People with a physician-confirmed diagnosis of stroke. Stroke may be ischaemic or haemorrhagic in nature.
  • People aged ≥18 years old; with confirmed mild to moderate cognitive impairment using the Oxford Cognitive Screen (OCS) (in accordance with cut-offs for impairment for OCS-plus subtasks (Demeyere et al. 2021a) and the Addenbroke's Examination III (ACE III) with a cut-off score of 88/100 (Takenoshita et al. 2019).
  • People post-stroke who have a Modified Rankin Scale (MRS) score of 0-3
  • Capacity to provide informed consent
  • People post-stroke who are able to express their basic needs, verbally or not
  • Have access to a smartphone, laptop or tablet with an internet connection
  • Willingness/ interest in participating in an online intervention
  • Physician-confirmed suitability to partake in this intervention

Who cannot join

  • Physician-confirmed contraindications for undertaking physical activity e.g., safety, presence of unstable heart disease
  • People with diagnosed TIA will be excluded
  • People post-stroke with known active delirium or dementia will be excluded
  • People post-stroke with a diagnosis of known pre-stroke cognitive impairment
  • People post-stroke with moderate or severe visuospatial neglect

Trial locations and contacts

1 site in 1 country.

Ireland1 site
  • University of Limerick

    Limerick

Other trials in Ireland

About this study

Official title: A Multicomponent Intervention to Rehabilitate Cognitive Impairment in People Post-stroke: Single-arm Feasibility Study

OptiCogs Online is a complex multicomponent intervention comprising of cognitive, physical activity and educational components.

Read the detailed description

OptiCogs Online was developed in accordance with the MRC framework for the development and evaluation of complex interventions. Given the known interactions and interconnectivity of cognitive domains required for optimal cognitive functioning post-stroke, a systematic review of 64 studies addressing all types of non-pharmacological rehabilitation interventions which may improve multiple cognitive domains in people post-stroke was conducted. Within this review, rehabilitation interventions were categorised as multicomponent interventions, physical activity interventions, cognitive rehabilitation interventions, NIBS protocols, occupational-based interventions and other interventions. The most consistent evidence in our systematic review and meta-analysis supported multicomponent interventions, with significant improvement demonstrated for general cognitive function and memory outcomes. Specifically, multicomponent interventions wherein a form of cognitive rehabilitation was conducted in conjunction with a form of physical activity were shown to improve cognitive functioning in people post-stroke.

As well as meta-analytic evidence, we drew from qualitative findings which explored the perspectives of PpS, caregivers and healthcare professionals on the design and delivery of an intervention to improve cognitive functioning in PpS. Qualitative findings and input from clinical experts emphasised the importance of information provision, peer support and meaningful engagement. As such, each component of OptiCogs Online is supplemented with an educational or 'cognitive education' session wherein group discussion covers different aspects of cognitive functioning. As well as drawing on findings from our qualitative study, this 'cognitive education' component is underpinned by the Bridges stroke self-management package and based on self-efficacy principles.

To this end, a complex multicomponent intervention comprising of cognitive, physical activity and educational components was developed in line with the MRC framework.

Being tested
OptiCogs Online
Keywords
Feasibility, Stroke, Cognitive impairment, Multicomponent rehabilitation
Medical subject headings
Myocardial Infarction, Cognitive Dysfunction, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OptiCogs OnlineOther

    A multicomponent intervention to rehabilitate cognitive deficits in people post-stroke

Study groups in NCT05414539
Study groupRoleWhat they receive
Intervention groupExperimentalOptiCogs Online is a 6-week telehealth intervention consisting of cognitive, physical activity and educational components. Cognitive component of the intervention: Throughout the six-week intervention period, there will be three individualised one-to-one cognitive sessions (occurring on week one, week three and week five), delivered by an occupational therapist. Physical activity: The physical activity component will be delivered via telehealth by a physiotherapist. * Aerobic: Progressions from Week 1-Week 6 will result in individual achieving 60 mins moderate intensity aerobic activity @ frequency of 3 times per week as tolerated. * Muscular strengthening: Progressions from Week 1-Week 6 will result in the person post-stroke achieving 10 strengthening exercises x 10 reps x 3 sets @ frequency of 3 times per week as tolerated. Cognitive education: The cognitive education component is underpinned by the Bridges stroke self-management package and based on self-efficacy principles.
Receives: Other: OptiCogs Online

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment rate

    The proportion of participants who are recruited to the study.

    Measured: 6 weeks

  2. Adherence rate

    The proportion of participants who adhere to the treatment protocol of 6 weeks. We will determine the level of adherence to the intervention protocol using the self-report diary.

    Measured: 6 weeks

  3. Adverse events

    Number of participants with adverse events as a measure of safety. Adverse events include a fall, illness, medical complication etc.

    Measured: 6 weeks

  4. Acceptability of OptiCogs Online

    The proportion of participants reporting that OptiCogs Online is acceptable. Acceptability (satisfaction) of the OptiCogs intervention will be assessed using a self-report questionnaire developed by the researchers containing 5-point Likert scales: 1= "strongly disagree"; 2= "disagree"; 3= "neutral"; 4= "agree"; 5= "strongly agree".

    Measured: 6 weeks

  5. Retention rate

    The proportion of participants who are lost to follow-up

    Measured: 6 weeks

Secondary outcomes (5)
  1. Oxford Cognitive Screen-plus (OCS-plus)

    Changes in cognitive function from pre-intervention to post-intervention in accordance with the cut-offs for impairment for OCS-Plus subtasks.

    Measured: 6 weeks

  2. Addenbrooke's Cognitive Assessment (III) ACE (III)

    Changes in cognitive function from pre-intervention to post-intervention in accordance with ACE III score out of 100.

    Measured: 6 weeks

  3. Fatigue severity scale (FSS)

    ). The FSS is a 9-item scale which measures the severity of fatigue and its effect on ADLs on a 7-point scale. The FSS is shown as a valid and reliable measure of fatigue in people post-stroke

    Measured: 6 weeks

  4. PROMIS-10 Physical Functioning

    • Physical function (PF) will be assessed using a physical functioning subset of the patient reported outcomes measurement information system (PROMIS) scale.

    Measured: 6 weeks

  5. Stroke Specific Quality of Life Scale

    • Mood and social participation will be assessed using the relevant subscales of the Stroke-Specific Quality of Life Scale-12 (SSQoL-12).

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2022
  2. Study start9 May 2022
  3. Primary completion24 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
A non-randomised single-arm feasibility study using a pre-test: post-test design.
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05414539
Sponsor's protocol ID
OptiCogs
Status last verified
Feb 2022
First submitted
21 Feb 2022
Last updated
2 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • O' Donoghue M, Boland P, Taylor S, Hennessy E, Murphy E, Leahy S, McManus J, Lisiecka D, Purtill H, Galvin R, Hayes S. OptiCogs: feasibility of a multicomponent intervention to rehabilitate people with cognitive impairment post-stroke. Pilot Feasibility Stud. 2023 Oct 18;9(1):178. doi: 10.1186/s40814-023-01300-7.

    PubMed 37853485

Questions about this trial

What is this clinical trial studying?

A study testing OptiCogs Online in people with Stroke, Cardiovascular and Cognitive Impairment, run by University of Limerick at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment rate (time frame: 6 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05414539, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in